全文获取类型
收费全文 | 26026篇 |
免费 | 2291篇 |
国内免费 | 88篇 |
专业分类
耳鼻咽喉 | 278篇 |
儿科学 | 643篇 |
妇产科学 | 451篇 |
基础医学 | 3492篇 |
口腔科学 | 455篇 |
临床医学 | 2874篇 |
内科学 | 6195篇 |
皮肤病学 | 295篇 |
神经病学 | 2255篇 |
特种医学 | 1021篇 |
外科学 | 3760篇 |
综合类 | 436篇 |
一般理论 | 11篇 |
预防医学 | 2086篇 |
眼科学 | 889篇 |
药学 | 1590篇 |
中国医学 | 57篇 |
肿瘤学 | 1617篇 |
出版年
2022年 | 155篇 |
2021年 | 405篇 |
2020年 | 261篇 |
2019年 | 485篇 |
2018年 | 490篇 |
2017年 | 405篇 |
2016年 | 405篇 |
2015年 | 449篇 |
2014年 | 677篇 |
2013年 | 1023篇 |
2012年 | 1497篇 |
2011年 | 1419篇 |
2010年 | 853篇 |
2009年 | 822篇 |
2008年 | 1407篇 |
2007年 | 1471篇 |
2006年 | 1504篇 |
2005年 | 1399篇 |
2004年 | 1385篇 |
2003年 | 1270篇 |
2002年 | 1250篇 |
2001年 | 551篇 |
2000年 | 494篇 |
1999年 | 445篇 |
1998年 | 296篇 |
1997年 | 267篇 |
1996年 | 243篇 |
1995年 | 273篇 |
1994年 | 224篇 |
1993年 | 183篇 |
1992年 | 420篇 |
1991年 | 349篇 |
1990年 | 349篇 |
1989年 | 350篇 |
1988年 | 346篇 |
1987年 | 322篇 |
1986年 | 289篇 |
1985年 | 285篇 |
1984年 | 262篇 |
1983年 | 255篇 |
1982年 | 207篇 |
1981年 | 182篇 |
1980年 | 181篇 |
1979年 | 203篇 |
1978年 | 183篇 |
1977年 | 188篇 |
1976年 | 141篇 |
1975年 | 131篇 |
1974年 | 151篇 |
1973年 | 129篇 |
排序方式: 共有10000条查询结果,搜索用时 328 毫秒
31.
A. Robert Spitzer Shalom Stahl David Yarnitsky Ernest W. Johnson John R. Wilson R. A. C. Hughes Stefania Morino Giovanni Antonini Kiyotoshi Kaneko Yoji Ohnishi Tetsushi Atsumi Isao Hozumi Tadashi Miyatake Tetsuo Furukawa James P. Knochel Ikuo Mineo Seiichiro Tarui Francis O. Walker Andrew J. Gitter Walter C. Stolov Nicholas J. Capozzoli 《Muscle & nerve》1996,19(4):531-538
32.
Elaine E. Francis 《American journal of human biology》1995,7(2):277-278
33.
34.
The effects of chemical exposure on the developing nervous system have been documented in both humans and animals for a variety of agents. However, the comparability of these effects has not been carefully evaluated to determine the predictability of animal models to adverse effects in humans. A workshop sponsored by the U.S. Environmental Protection Agency (EPA) and the National Institute on Drug Abuse was held on April 11-13, 1989, to address the Qualitative and Quantitative Comparability of Human and Animal Developmental Neurotoxicity. Invited experts were asked to review the human and animal data on several agents that are known to cause developmental neurotoxicity in humans, including lead, methylmercury, selected abused agents, anticonvulsants, polychlorinated biphenyls (PCBs), ethanol and X-irradiation, and to make quantitative comparisons on a specific end point basis as well as on a functional category basis. In addition, they were asked to make quantitative comparisons when adequate dose-effect data were available. The data also were evaluated in the context of the proposed EPA developmental neurotoxicity testing battery to determine whether or not the battery would adequately detect the effects of each agent. Finally, four work groups were asked to reach consensus on issues relating to: 1) comparability of end points across species for developmental neurotoxicity; 2) testing methods in developmental neurotoxicity for use in human risk assessment; 3) weight-of-evidence and quantitative evaluation of data from developmental neurotoxicity studies; and 4) triggers for developmental neurotoxicity testing. 相似文献
35.
John K. Brooks Claire O. Leonard Peter J. Coccaro 《American journal of medical genetics. Part A》1992,43(3):595-601
We studied a new case of the G (Opitz BBB/G) syndrome in a 12-year-old boy. Several relatives had partial manifestations of the disorder. A comprehensive dental evaluation of the propositus was conducted; included is, to our knowledge, the first published cephalometric analysis of a G syndrome patient. We reviewed 139 cases of the G syndrome; 48 of them had at least one oral abnormality. These included clefting, micrognathia, ankyloglossia, and high-arched palate. Male G syndrome patients are more likely to have oral anomalies than affected females. © 1992 Wiley-Liss, Inc. 相似文献
36.
Choc Miles G. Hsuan Francis Honigfeld Gilbert Robinson William T. Ereshefsky Larry Crismon Miles L. Saklad Stephen R. Hirschowitz Jack Wagner Richard 《Pharmaceutical research》1990,7(4):347-351
Clozapine plasma levels were monitored in 16 patients during a series of three consecutive treatments (single dose-multiple dose-single dose). Each patient received a single 75-mg dose (3 x 25 mg) with clozapine tablets, and serial plasma samples were collected over 48 hr after the dose. At 48 hr, a multiple-dose regimen was started, consisting of an initial dose escalation period followed by dosing at a constant regimen for at least 6 days. After the last dose, serial plasma samples were again obtained over 72 hr. Drug was then withheld for at least 7 days, a final single 75-mg dose was given, and plasma sampling was repeated. A subset of the patient population (N = 7) was used to test for a food effect during the single-dose treatments. The pharmacokinetic parameters between the initial and the final single dose periods were not significantly different. Similarly, there were no differences within patients when given the dose after fasting (fed 1 hr after dose) or with a meal. In contrast, the terminal elimination rate differed between the single-dose and the multiple-dose treatments (t1/2 m3 = 7.9 hr single dose and 14.2 hr multiple dose) (P less than 0.05) and the dose-normalized area under the plasma concentration/time curves increased 27% with multiple dosing. Since a previous study in patients (Choc et al., Pharm. Res. 4:402-405, 1987) showed dose proportionality of clozapine plasma concentrations during multiple-dose regimens, the present results cannot be described by Michaelis-Menten kinetics. 相似文献
37.
38.
K L Leenders R S Frackowiak N Quinn D Brooks D Sumner C D Marsden 《Movement disorders》1986,1(1):51-58
A patient developed progressive right hemidystonia in childhood. Subsequently, left-sided blepharospasm, slurred and stuttering speech, and right-sided rigidity and bradykinesia, responsive to dopamine agonists, appeared. Investigation with computed tomography and magnetic resonance imaging (MRI) at age 43 years revealed a left-sided calcified rostral brainstem-thalamic lesion of uncertain aetiology. Although no structural lesion was seen in the striatal regions, L-[18F]-fluorodopa uptake was severely diminished in the left striatum but normal on the right. Dopamine receptor binding identified by [11C]-methylspiperone was in the normal range on both sides. 相似文献
39.
Direct excitatory effects of neuropeptide Y (NPY) on rat hippocampal neurones in vitro 总被引:3,自引:0,他引:3
Intracellular recordings from granule cells of the rat dentate gyrus show neuropeptide Y (NPY) applied by pressure ejection from pipettes containing 1.2-12 microM by pressures of less than 200 kPa for 1-5 s in duration to consistently evoke membrane depolarisations accompanied by a reduction in membrane resistance. The depolarisations were accompanied by an increase in excitability. Since the depolarisations evoked by NPY were not attenuated by either tetrodotoxin or kynurenic acid a direct excitatory action of NPY is postulated. 相似文献
40.